Promised objectives included ending COVID vaccine mandates, maintaining vaccine availability for those who want them, especially vulnerable groups, demanding placebo-controlled trials, and concluding the emergency status. Recent FDA actions have fulfilled all these goals, rescinding emergency use authorizations and instead granting marketing authorizations for those at higher risk: Moderna for ages 6 months and older, Pfizer for ages 5 and older, and Novavax for ages 12 and older. These vaccines are now available for anyone, in consultation with their healthcare providers. The framework prioritizes science, safety, and common sense.
You are viewing a single comment's thread from: